Literature DB >> 15823033

The N-terminal extracellular domain 23-60 of the calcitonin receptor-like receptor in chimeras with the parathyroid hormone receptor mediates association with receptor activity-modifying protein 1.

Lars M Ittner1, Daniela Koller, Roman Muff, Jan A Fischer, Walter Born.   

Abstract

The calcitonin receptor-like receptor (CLR) requires the associated receptor activity-modifying protein (RAMP)1 to reveal a calcitonin gene-related peptide (CGRP) receptor. Here, the subdomain of the CLR that associates with RAMP1 has been identified in chimeras between the CLR and the parathyroid hormone (PTH) receptor 1 (PTHR). The PTHR alone does not interact with RAMP1. RAMP1 requires the CLR for its transport to the cell surface. Thus, receptor-dependent RAMP1 delivery to the plasma membrane and coimmunoprecipitation from the cell surface were used as measures for receptor/RAMP1 interaction. Several chimeric CLR-PTHR included the N-terminal amino acids 23-60 of the CLR transported RAMP1 to the surface of COS-7 cells much like the intact CLR. Moreover, RAMP1 coimmunoprecipitated with these receptors from the cell surface. A CLR deletion mutant, consisting of the N-terminal extracellular domain, the first transmembrane domain, and the C-terminal intracellular region, revealed the same results. Cyclic AMP was stimulated by CGRP in CLR/RAMP1 expressing cells (58 +/- 19-fold, EC(50) = 0.12 +/- 0.03 nM) and by PTH-related protein in cells expressing the PTHR (50 +/- 10-fold, EC(50) = 0.25 +/- 0.03 nM) or a PTHR with the N-terminal amino acids 23-60 of the CLR (23 +/- 5-fold, EC(50) > 1000 nM). Other chimeric CLR-PTHR were inactive. In conclusion, structural elements in the extreme N-terminus of the CLR between amino acids 23-60 are required and sufficient for CLR/RAMP1 cotransport to the plasma membrane and heterodimerization.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15823033     DOI: 10.1021/bi048111o

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  21 in total

1.  Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models.

Authors:  Janet van Eersel; Yazi D Ke; Xin Liu; Fabien Delerue; Jillian J Kril; Jürgen Götz; Lars M Ittner
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-19       Impact factor: 11.205

Review 2.  Regulation of G protein-coupled receptor export trafficking.

Authors:  Chunmin Dong; Catalin M Filipeanu; Matthew T Duvernay; Guangyu Wu
Journal:  Biochim Biophys Acta       Date:  2006-09-23

3.  CNS cell type-specific gene profiling of P301S tau transgenic mice identifies genes dysregulated by progressive tau accumulation.

Authors:  Yazi D Ke; Gabriella Chan; Kristie Stefanoska; Carol Au; Mian Bi; Julius Müller; Magdalena Przybyla; Astrid Feiten; Emmanuel Prikas; Glenda M Halliday; Olivier Piguet; Matthew C Kiernan; Michael Kassiou; John R Hodges; Clement T Loy; John S Mattick; Arne Ittner; Jillian J Kril; Greg T Sutherland; Lars M Ittner
Journal:  J Biol Chem       Date:  2019-07-31       Impact factor: 5.157

4.  ERK inhibition with PD184161 mitigates brain damage in a mouse model of stroke.

Authors:  Amadeus Gladbach; Janet van Eersel; Mian Bi; Yazi D Ke; Lars M Ittner
Journal:  J Neural Transm (Vienna)       Date:  2013-12-14       Impact factor: 3.575

Review 5.  Calcitonin and calcitonin receptor-like receptors: common themes with family B GPCRs?

Authors:  James Barwell; Joseph J Gingell; Harriet A Watkins; Julia K Archbold; David R Poyner; Debbie L Hay
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

6.  Bacterial expression and purification of a heterodimeric adrenomedullin receptor extracellular domain complex using DsbC-assisted disulfide shuffling.

Authors:  Heather E Hill; Augen A Pioszak
Journal:  Protein Expr Purif       Date:  2012-12-13       Impact factor: 1.650

7.  Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.

Authors:  Lars M Ittner; Yazi D Ke; Jürgen Götz
Journal:  J Biol Chem       Date:  2009-06-02       Impact factor: 5.157

8.  Phosphorylation of soluble tau differs in Pick's disease and Alzheimer's disease brains.

Authors:  Janet van Eersel; Mian Bi; Yazi D Ke; John R Hodges; John H Xuereb; Gillian C Gregory; Glenda M Halliday; Jürgen Götz; Jillian J Kril; Lars M Ittner
Journal:  J Neural Transm (Vienna)       Date:  2009-08-20       Impact factor: 3.575

9.  Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer's disease.

Authors:  Yazi D Ke; Fabien Delerue; Amadeus Gladbach; Jürgen Götz; Lars M Ittner
Journal:  PLoS One       Date:  2009-11-19       Impact factor: 3.240

10.  Mapping interaction sites within the N-terminus of the calcitonin gene-related peptide receptor; the role of residues 23-60 of the calcitonin receptor-like receptor.

Authors:  James Barwell; Philip S Miller; Dan Donnelly; David R Poyner
Journal:  Peptides       Date:  2009-11-11       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.